A
A

Aviva

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK health insurance rates to soar on surging claims-industry experts

UPDATE 1-UK health insurance rates to soar on surging claims-industry experts Adds more detail para 19 By Carolyn Cohn LONDON, Nov 30 (Reuters) - Health insurance rates in Britain are likely to soar by at least 20% next year due to the surging number and cost of claims, industry advisers say. British employers have expanded the use of company health schemes as the country's National Health Service struggles to meet patient demand in the aftermath of the COVID-19 pandemic.
A
A

UK Stocks-Factors to watch on Nov. 30

UK Stocks-Factors to watch on Nov. 30 Nov 30 (Reuters) - Britain's FTSE 100 index .FTSE is expected to open higher on Thursday, with futures FFIc1 up 0.09%. * CAR PRODUCTION : British vehicle makers are expected to produce about a million cars this year, well above an earlier forecast, following a recent round of investments in the sector, an industry body said on Thursday.
A
U

Top of the Street: BMW, Vestas, Aviva, Equinor

BUZZ-Top of the Street: BMW, Vestas, Aviva, Equinor A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** J.P.Morgan upgrades German auto maker BMW BMWG.DE to "overweight" from "neutral" saying the stock offers the highest yoy premium growth rate ** Berenberg raises Danish wind turbine maker Vestas VWS.CO to "buy" from "hold" citing better margins, expected improvement in 2024 order intake, and potential for market share gains from challenged competitors ** De
A
B
E
J
L
L

FTSE 100 slips for the third day as financials weigh

UPDATE 2-FTSE 100 slips for the third day as financials weigh For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Aviva falls on brokerage downgrade British home prices to dip again in 2024 BoE's Bailey vows to do 'what it takes' to cut inflation FTSE 100 down 0.4%, FTSE 250 adds 0.4% Updated at 16:53 GMT By Shashwat Chauhan and Khushi Singh Nov 29 (Reuters) - Britain's FTSE 100 slipped for the third straight day on Wednesday following hawki
A
E
G
H
J
P
S
U

Adevinta ASA, Anglo American, BMW

EUROPE RESEARCH ROUNDUP-Adevinta ASA, Anglo American, BMW Nov 29 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adevinta ASA, Anglo American, and BMW, on Wednesday. HIGHLIGHTS * Adevinta ASA ADEA.OL : Jefferies cuts to hold from buy * Anglo American AAL.L : Berenberg cuts target price to 2200p from 2500p * Aviva Plc AV.L : Deutsche Bank cuts to hold from buy * BMW BMWG.DE : JP Morgan raises to overweight from neutral * Direct Line
A
A
A
A
A
B
B
B
B
B
E
E
E
E
G
L
M
N
O
P
R
S
S
U
V
V
A
A
D
D
G
I
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.